You can find the annual or quarterly income statement of LakeShore Biopharma Co Ltd here for insights into the performance and operational efficiency of LakeShore Biopharma Co Ltd.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025H1

FY2024H2

FY2024H1

Total revenue

34.25%50.98M

--41.87M

--37.97M

Revenue

34.25%50.98M

--41.87M

--37.97M

Cost of revenue

22.17%8.86M

--9.13M

--7.26M

Operating expenses

-26.33%46.75M

--56.53M

--63.45M

R&D expenses

-62.25%9.39M

--17.28M

--24.87M

Depreciation, depletion, and amortization

25.67%3.48M

--3.10M

--2.77M

Operating profit

116.60%4.23M

---14.66M

---25.48M

Net non-operating interest income (expenses)

Non-operating interest income

----

--272.19K

Non-operating interest expense

-56.59%900.84K

----

--2.08M

Gains from sale of securities

----

---6.18M

----

Special income (expenses)

-95.47%43.17K

---22.28M

--952.63K

- Gains from disposal of fixed assets

---1.13M

----

Other non-operating income (expenses)

-62.02%741.04K

--2.30M

--1.95M

Income before tax

112.25%2.99M

---39.01M

---24.38M

Income tax

246.35%166.93K

---2.91M

---114.06K

Income after tax

111.62%2.82M

---36.10M

---24.27M

Net income from continuous operations

111.62%2.82M

---36.10M

---24.27M

Net income attributable to controlling interests

111.62%2.82M

---36.10M

---24.27M

Preferred share dividend

----

--0.00

----

Net income attributable to common shareholders

111.62%2.82M

---36.10M

---24.27M

Basic earnings per share

105.68%0.15

---2.99

---2.61

Diluted earnings per share

105.68%0.15

---2.99

---2.61

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

